<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29617" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Subconjunctival Hemorrhage</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Doshi </surname>
            <given-names>Ricky</given-names>
          </name>
          <aff>Wellstar Kennestone</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Noohani</surname>
            <given-names>Tariq</given-names>
          </name>
          <aff>Wellstar Kennestone Regional Med. Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ricky Doshi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tariq Noohani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29617.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Subconjunctival hemorrhage is a common ocular complaint that most clinicians will see in their practice. This&#x000a0;topic describes its causes and the context in which SCH can be present. The&#x000a0;topic will summarize the evaluation and further management to help clinicians treat and guide patients who present with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the etiologies of subconjunctival hemorrhage.</p></list-item><list-item><p>Assess&#x000a0;pertinent aspects of the medical history regarding the context surrounding a subconjunctival hemorrhage.</p></list-item><list-item><p>Evaluate&#x000a0;the treatment and management options available for subconjunctival hemorrhage.</p></list-item><list-item><p>Communicate&#x000a0;interprofessional team strategies for improving care coordination to advance subconjunctival hemorrhage and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29617&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29617">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29617.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Red eyes are a common complaint in emergency departments and outpatient clinics. One frequent cause is a subconjunctival hemorrhage (SCH) (see <bold>Image.</bold>&#x000a0;Subconjunctival Hemorrhage). SCH is a disorder that can occur, for the most part, in benign situations. However, there are certain times when&#x000a0;SCH can occur as a manifestation of a more dangerous underlying diagnosis, especially if persistent or recurrent. SCH is generally painless but can appear as diffusely hyperemic. Therefore, physicians, advanced practice providers, and ophthalmologists can encounter SCH throughout their clinical practice. The conjunctiva is divided into&#x000a0;2 sections. The bulbar conjunctiva covers the sclera, and the tarsal conjunctiva covers the inside of the eyelids. The blood from an SCH comes from small blood vessels on the surface of the eye over the sclera and not from the inside of the eye. Blood leaks under Tenon's capsule, and the condition becomes more apparent when blood leaks into the externally exposed part of the bulbar conjunctiva. Elderly patients, especially those with underlying vascular disorders such as hypertension and diabetes, are most at risk. Younger patients tend to have more spontaneous or traumatic causes. Nevertheless, SCH usually does not require specific treatment and should resolve in 1-2 weeks.<xref ref-type="bibr" rid="article-29617.r1">[1]</xref><xref ref-type="bibr" rid="article-29617.r2">[2]</xref><xref ref-type="bibr" rid="article-29617.r3">[3]</xref></p>
      </sec>
      <sec id="article-29617.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>SCH can be differentiated into&#x000a0;2 categories: traumatic vs spontaneous. Traumatic incidences of SCH have risen secondary to the increased use of contact lenses as well as the number of people undergoing ocular surgeries. Contact lens wearers have a higher tendency to have conjunctivochalasis, pinguecula, and superficial punctate keratitis. These conjunctival diseases can cause increased inflammation through dryness, friction between the lenses and conjunctiva itself, and possible disruption of tear flow. Material defects and surface deposits in hard lenses and defects at the rims with prolonged use of disposable contact lenses can promote SCH.<xref ref-type="bibr" rid="article-29617.r4">[4]</xref><xref ref-type="bibr" rid="article-29617.r5">[5]</xref></p>
        <p>Ocular surgeries, especially in patients on anticoagulation, increase the risk for SCH. Cataract surgery, refractive surgery, and local anesthesia, such as sub-Tenon injections, can potentiate SCH. Local minor trauma such as eye rubbing or a foreign body can cause SCH. For this reason, the patient may not recall any minor trauma. In cases with extensive trauma, SCH may be present in the scope of a more devastating injury, such as an open globe. SCH may develop after orbital fractures. Basilar skull fractures can be identified if SCH is coming from the fornix when globe trauma is not present.<xref ref-type="bibr" rid="article-29617.r6">[6]</xref></p>
        <p>Nonaccidental trauma should be considered in infants who present with bilateral isolated&#x000a0;SCH, especially if they are associated with facial petechiae. Traumatic asphyxia syndrome, which is caused by prolonged compression of a child's upper abdomen and chest, can cause sudden severe venous congestion.<xref ref-type="bibr" rid="article-29617.r7">[7]</xref>&#x000a0;Conversely, SCH in newborns can be normal after a vaginal delivery with an estimated incidence of 1-2%. The mechanism is the same as above; however, uterine contractions provide the compression.<xref ref-type="bibr" rid="article-29617.r8">[8]</xref></p>
        <p>The biggest risk factor for spontaneous SCH is hypertension and other vascular disorders like diabetes and hyperlipidemia. These diseases can cause blood vessels to become fragile and spontaneously rupture. Hypertension is the major risk factor for SCH, regardless of whether the blood pressure is controlled by medication. Spontaneous SCH has also been shown to be a predictor of hypertension if shown to be high on initial presentation and subsequently at a 1 and 4-week follow-up.<xref ref-type="bibr" rid="article-29617.r9">[9]</xref><xref ref-type="bibr" rid="article-29617.r10">[10]</xref>&#x000a0;</p>
        <p>People who have vascular disorders also may be placed on anticoagulation such as warfarin or heparin. NSAIDs such as aspirin and P2Y12 inhibitors such as clopidogrel can also increase the risk for SCH. A risk of SCH is still present even if INR is in the therapeutic range.<xref ref-type="bibr" rid="article-29617.r11">[11]</xref> Spontaneous causes include elevated venous pressures such as coughing, vomiting, strenuous exercise/lifting, and Valsalva maneuvers. Acute hemorrhagic conjunctivitis caused most commonly by enterovirus 70 can cause widely extensive SCH, however, the prevalence of this disease is declining. Menstruation can cause SCH, likely secondary to an underlying blood dyscrasia or venous pressure. There are many other diseases whose initial presentation has been associated with SCH, including Steven-Johnson syndrome, hemochromatosis, and dermatologic vasculature diseases such as Kaposi's sarcoma, pyogenic granuloma, telangiectasias, and hemangiomas. Still, almost half of spontaneous cases of SCH are idiopathic in etiology.</p>
      </sec>
      <sec id="article-29617.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>SCHs, in general, do not have any gender discrepancy. However, traumatic SCH was shown to be more prevalent in young males, most likely related to performing heavy work and a tendency to do more aggressive activities. The rate of spontaneous vs traumatic varies depending on the population characteristics themselves. One study showed the incidence rate of non-traumatic SCH to be higher in women, with a men-to-women ratio of 0.8. It is widely agreed that spontaneous SCH increases with age, especially after 50. This is due to the higher probability of comorbidities such as hypertension, hyperlipidemia, and diabetes mellitus. According to&#x000a0;1 study, there is also an increased incidence of SCH in the summer; however, this may be secondary to children presenting more often during summer vacation.<xref ref-type="bibr" rid="article-29617.r3">[3]</xref><xref ref-type="bibr" rid="article-29617.r12">[12]</xref><xref ref-type="bibr" rid="article-29617.r13">[13]</xref></p>
      </sec>
      <sec id="article-29617.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>SCH results from bleeding of the conjunctival or episcleral blood vessels and subsequently leaks into the subconjunctival space. Blood vessels can wear and tear over time. The elastic and connective tissues become fragile with age and underlying comorbidities, which can ease the spread of the bleeding in the elderly. Traumatic SCH is more localized to the site of impact compared to spontaneous. There is a predilection for SCH to develop on the temporal aspect of the eye since the bulbar conjunctiva of the temporal aspect is larger than the nasal aspect. Other reasons include increased incidence of conjunctivochalasis, protection of the nose on the nasal aspect, and more difficulty detecting projectiles on the temporal aspect. The inferior aspect was noted to have an increased incidence of SCH compared to the superior, likely to have blood gravitating downwards after the insult.<xref ref-type="bibr" rid="article-29617.r14">[14]</xref><xref ref-type="bibr" rid="article-29617.r2">[2]</xref><xref ref-type="bibr" rid="article-29617.r4">[4]</xref></p>
      </sec>
      <sec id="article-29617.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathologically, the bleeding itself occurs between the conjunctiva and the episclera. Specifically, the blood elements are found in the substantia propria. The eye may turn blue and yellow as the hemoglobin and other blood elements break down, similar to a bruise.&#x000a0;</p>
      </sec>
      <sec id="article-29617.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A careful history and physical examination are key to determining whether an SCH is benign or a sign of something more malignant. Sometimes, a patient may be unaware of a problem until he or she looks in a mirror or is told by someone else. A clinician should determine what type of ocular trauma, if any, occurred. A&#x000a0;SCH in the setting of blunt trauma is worrisome and should be evaluated for possible ruptured globe or retrobulbar hematoma. Be sure to obtain past medical history, especially vascular disorders like hypertension, hyperlipidemia, and diabetes. Be sure to note any anticoagulant therapy, underlying coagulopathy, or blood dyscrasia. Note any non-compliance with medications, use of contact lenses, and any prior ocular surgeries. The clinician should also determine any viral-like illnesses, coughing, vomiting, or constipation. A history of visual loss, discharge, photophobia, foreign body sensation, or headache should prompt the clinician to investigate other etiologies.&#x000a0;</p>
        <p>On the physical exam, SCH is a painless, acute, sharply demarcated area of extravasated blood beneath the eye's surface. SCH is generally unilateral. There is no reduction in visual acuity. A traumatic SCH should be more localized, and if it is spontaneous and elderly, the SCH could be more diffuse. The inferotemporal aspect of the conjunctiva is the most common site. A simple SCH should not have any chemosis, proptosis, purulent discharge, or ophthalmoplegia. In instances of scleral rupture, intraocular blood can leak through a defect and collect in the subconjunctival space, which can create an elevated, bullous-appearing hemorrhage.<xref ref-type="bibr" rid="article-29617.r2">[2]</xref></p>
        <p>A key aspect of the physical exam is distinguishing between conjunctival versus ciliary injection. Conjunctival hemorrhage is caused by dilation of the posterior and more superficial conjunctival vessels. This can cause the eye to appear red in a continuous pattern over the sclera. In contrast, ciliary injection involves dilation of the anterior ciliary arteries, which could imply intraocular inflammation of the iris, cornea, or ciliary body. The ciliary injection can also be known as circumcorneal flush and appears as a halo of redness. The distinction is important since ciliary injection is associated with potentially more dangerous diagnoses such as iritis, acute glaucoma, episcleritis, and scleritis.<xref ref-type="bibr" rid="article-29617.r15">[15]</xref>&#x000a0;SCH can also be confused for viral or bacterial conjunctivitis. However, there is usually some degree of pain associated with these diagnoses. Additionally, on physical exam, the redness is more diffuse and not a discreet, confluent area of hemorrhagic change as seen in SCH. Viral conjunctivitis is bilateral, and in most cases, SCH is unilateral.<xref ref-type="bibr" rid="article-29617.r15">[15]</xref></p>
      </sec>
      <sec id="article-29617.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>SCH's initial evaluation and determination are clinical and based on appearance. However, a careful slit-lamp with fluorescein examination is important to determine any ocular trauma or possible underlying local ocular condition, which can lead to an SCH. All patients presenting with SCH should have blood pressure checked routinely. An INR should be checked if a patient is taking warfarin. If the SCH becomes persistent or recurrent, then a workup regarding bleeding disorders and other hypocoagulable states should be done. However, it should be noted that extensive hemostatic testing is not warranted in the absence of other bleeding symptoms and solely SCH. Fundoscopy is generally not indicated.<xref ref-type="bibr" rid="article-29617.r2">[2]</xref><xref ref-type="bibr" rid="article-29617.r9">[9]</xref><xref ref-type="bibr" rid="article-29617.r16">[16]</xref>]&#x000a0;</p>
      </sec>
      <sec id="article-29617.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Generally, no treatment is indicated for SCH unless associated with a certain serious condition. The blood is typically resorbed over 1-2 weeks, depending on the amount of extravasated blood. Recovery may take up to 3 weeks if patients are on anticoagulation. Ice packs and artificial tears can minimize tissue swelling and relieve discomfort. Emergent ophthalmology consultation is warranted if SCH occurs via trauma and intraocular or additional retinal trauma is suspected. Dilute brimonidine and oxymetazoline have been indicated to improve patient comfort and decrease the incidence of SCH after intravitreal injections.<xref ref-type="bibr" rid="article-29617.r2">[2]</xref><xref ref-type="bibr" rid="article-29617.r17">[17]</xref><xref ref-type="bibr" rid="article-29617.r18">[18]</xref></p>
      </sec>
      <sec id="article-29617.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>If orbital trauma is suspected, globe rupture and retrobulbar hematoma are diagnoses that must be ruled out as this is sight-threatening and requires an emergent ophthalmology consult. In the setting of trauma, one must also consider corneal abrasion, conjunctival laceration, ocular foreign body, traumatic iritis, and traumatic hyphema. Differential for non-traumatic cases include conjunctivitis, episcleritis, inflamed pterygium or pinguecula, corneal erosions, keratitis, and anterior uveitis. One must also rule out acute angle-closure glaucoma, corneal ulcer, endophthalmitis, and scleritis, as these are ophthalmologic emergencies.</p>
        <p>A more dangerous etiology can often be found just by simple observation. A patient with a globe rupture or retrobulbar hematoma could have some degree of proptosis, chemosis, decreased visual acuity, or a tear-drop-shaped pupil. The physical exam can also help to distinguish other eye disorders, such as an afferent pupillary defect in the setting, optic neuropathy, or consensual photophobia in the setting of iritis. The slit lamp exam with fluorescein staining can be a very useful adjunct in the exam to better investigate possible erosions, ulcers, and dendrites. Many of these patients could have symptoms of grittiness or a foreign body sensation, which should not be present in the case of a simple SCH.&#x000a0;</p>
      </sec>
      <sec id="article-29617.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>SCH offers a good visual prognosis after resolution. Vision is generally not impaired. The recurrence rate for spontaneous SCH is about 10% without identifiable risk factors and higher if patients take anticoagulant or antiplatelet therapy.<xref ref-type="bibr" rid="article-29617.r16">[16]</xref></p>
      </sec>
      <sec id="article-29617.s12" sec-type="Complications">
        <title>Complications</title>
        <p>There are no complications surrounding&#x000a0;SCH, as most resolve around 2 weeks. SCH&#x000a0;itself may be a sign of a more underlying dangerous disorder such as coagulopathy, severe asthma exacerbation, non-accidental trauma, or severe orbital trauma.<xref ref-type="bibr" rid="article-29617.r19">[19]</xref></p>
      </sec>
      <sec id="article-29617.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>SCH generally subsides within&#x000a0;2 weeks. If patients notice recurrence or persistence of SCH or bruising on other parts of the body, especially if taking anticoagulation or antiplatelet therapy, their general practitioner or cardiologist may organize further tests. Artificial tears may help if the eye feels gritty or full. Patients should contact their primary care doctor or seek a specialist if there is vision loss, ophthalmoplegia, or increasing pain and swelling.&#x000a0;</p>
      </sec>
      <sec id="article-29617.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>SCH is a frequently encountered complaint in medical practice. Many patients do not experience any symptoms except for the physical appearance of the bleeding itself. The cause of a SCH usually comes from a lack of identifiable etiology. Mostly, they are of benign origin, including increased strain, Valsalva, and contact lens usage.&#x000a0;But in some instances, there can be a systemic predisposing risk factor, and further work-up is needed to prevent further morbidity and mortality.&#x000a0;Many different types of medical professionals can encounter SCH. The primary care provider, emergency physicians, and ocular specialists can all be involved in caring for patients with SCH. It can be important to consult with your interprofessional team to discuss the patient's diagnosis and collaborate on further care. Nurses and pharmacists are vital interprofessional team members who monitor patients' vital signs and potentially adjust medications. The ophthalmologist is an important component of the interprofessional team since patients can hopefully follow up with these specialists and further coordinate care. In addition, some patients may have SCHs caused by anticoagulation. Therefore, consulting with one's cardiologist/vascular surgeon or whoever monitors a patient's anticoagulation is important. SCH can also be present in newborns and children, therefore, neonatalogists, pediatricians, pediatric emergency physicians could be involved. It is important to note that SCHs can be present in the context of non-accidental trauma, so the clinician must be vigilant for signs of child abuse.&#x000a0;</p>
      </sec>
      <sec id="article-29617.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29617&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29617">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/subconjunctival-hemorrhage/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29617">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29617/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29617">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29617.s16">
        <fig id="article-29617.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Subconjunctival Hemorrhage. This image&#x000a0;shows a subconjunctival hemorrhage in a patient on anticoagulant medication. Contributed by Stephan Moll, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="subcontival__hemorrhage__-__warfarin" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29617.s17">
        <title>References</title>
        <ref id="article-29617.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cronau</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kankanala</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Mauger</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of red eye in primary care.</article-title>
            <source>Am Fam Physician</source>
            <year>2010</year>
            <month>Jan</month>
            <day>15</day>
            <volume>81</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-44</page-range>
            <pub-id pub-id-type="pmid">20082509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tarlan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kiratli</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Subconjunctival hemorrhage: risk factors and potential indicators.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2013</year>
            <volume>7</volume>
            <fpage>1163</fpage>
            <page-range>1163-70</page-range>
            <pub-id pub-id-type="pmid">23843690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahinoglu-Keskek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cevher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ergin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Analysis of subconjunctival hemorrhage.</article-title>
            <source>Pak J Med Sci</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>132</fpage>
            <page-range>132-4</page-range>
            <pub-id pub-id-type="pmid">24353524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Funatsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Noma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Contact lens-induced subconjunctival hemorrhage.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>150</volume>
            <issue>5</issue>
            <fpage>656</fpage>
            <page-range>656-665.e1</page-range>
            <pub-id pub-id-type="pmid">20709310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The tear film characteristics of spontaneous subconjunctival hemorrhage patients detected by Schirmer test I and tear interferometry.</article-title>
            <source>Mol Vis</source>
            <year>2012</year>
            <volume>18</volume>
            <fpage>1952</fpage>
            <page-range>1952-4</page-range>
            <pub-id pub-id-type="pmid">22876120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>KING</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>WALSH</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Trauma to the head with particular reference to the ocular signs; injuries involving the hemispheres and brain stem; miscellaneous conditions; diagnostic principles; treatment.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1949</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>379</fpage>
            <page-range>379-98</page-range>
            <pub-id pub-id-type="pmid">18112994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitzer</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Luorno</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>No&#x000eb;l</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Isolated subconjunctival hemorrhages in nonaccidental trauma.</article-title>
            <source>J AAPOS</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-6</page-range>
            <pub-id pub-id-type="pmid">15729281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katzman</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of neonatal subconjunctival hemorrhage.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>149</fpage>
            <page-range>149-52</page-range>
            <pub-id pub-id-type="pmid">1547586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kittisupamongkol</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Blood pressure in subconjunctival hemorrhage.</article-title>
            <source>Ophthalmologica</source>
            <year>2010</year>
            <volume>224</volume>
            <issue>5</issue>
            <fpage>332; author reply 332</fpage>
            <pub-id pub-id-type="pmid">20431313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pitts</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Jardine</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous subconjunctival haemorrhage--a sign of hypertension?</article-title>
            <source>Br J Ophthalmol</source>
            <year>1992</year>
            <month>May</month>
            <volume>76</volume>
            <issue>5</issue>
            <fpage>297</fpage>
            <page-range>297-9</page-range>
            <pub-id pub-id-type="pmid">1390514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bodack</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>A warfarin-induced subconjunctival hemorrhage.</article-title>
            <source>Optometry</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>78</volume>
            <issue>3</issue>
            <fpage>113</fpage>
            <page-range>113-8</page-range>
            <pub-id pub-id-type="pmid">17321459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Funatsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Recent causes of subconjunctival hemorrhage.</article-title>
            <source>Ophthalmologica</source>
            <year>2010</year>
            <volume>224</volume>
            <issue>3</issue>
            <fpage>133</fpage>
            <page-range>133-7</page-range>
            <pub-id pub-id-type="pmid">19738393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Mou</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chao</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Nien</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Kuan</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Incidence of Non-Traumatic Subconjunctival Hemorrhage in a Nationwide Study in Taiwan from 2000 to 2011.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>e0132762</fpage>
            <pub-id pub-id-type="pmid">26181776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Usui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Funatsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fukuoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hotta</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Location and extent of subconjunctival hemorrhage.</article-title>
            <source>Ophthalmologica</source>
            <year>2010</year>
            <volume>224</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-5</page-range>
            <pub-id pub-id-type="pmid">19713719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powdrill</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ciliary injection: a differential diagnosis for the patient with acute red eye.</article-title>
            <source>JAAPA</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>12</issue>
            <fpage>50</fpage>
            <page-range>50-4</page-range>
            <pub-id pub-id-type="pmid">21229837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cagini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iannone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bartolini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fiore</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fierro</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gresele</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Reasons for visits to an emergency center and hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>188</fpage>
            <page-range>188-92</page-range>
            <pub-id pub-id-type="pmid">26480948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzalez-Saldivar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pita-Ortiz</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Flores-Villalobos</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Jaurrieta-Hinojos</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Espinosa-Soto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rios-Nequis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ramirez-Estudillo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jimenez-Rodriguez</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Oxymetazoline: reduction of subconjunctival hemorrhage incidence after intravitreal injections.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>513</fpage>
            <page-range>513-516</page-range>
            <pub-id pub-id-type="pmid">31358153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasquali</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Aufderheide</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brinton</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Avila</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Stahl</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Durrie</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Dilute brimonidine to improve patient comfort and subconjunctival hemorrhage after LASIK.</article-title>
            <source>J Refract Surg</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>7</issue>
            <fpage>469</fpage>
            <page-range>469-75</page-range>
            <pub-id pub-id-type="pmid">23820229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29617.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Roisin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agust&#x000ed;</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Ussetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Agust&#x000ed;-Vidal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Subconjunctival haemorrhage: a feature of acute severe asthma.</article-title>
            <source>Postgrad Med J</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>61</volume>
            <issue>717</issue>
            <fpage>579</fpage>
            <page-range>579-81</page-range>
            <pub-id pub-id-type="pmid">4022890</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
